Keywords: bioalliance, sets, up, spebio, loramyc, french, specialty

BioAlliance sets up SpeBio for Loramyc

Article | 25 June 2007

Print This

French specialty firm BioAlliance Pharma has set up a new subsidiary, SpeBio, to sell its oropharyngeal candidiasis drug Loramyc (miconazole ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in